N-terminal Pro B-type Natriuretic Peptide Levels: Correlation with Echocardiographically Determined Left Ventricular Diastolic Function in an Ambulatory Cohort

Journal of the American Society of Echocardiography

Volumn 19, Issue 8, 2006, Pages 1017-1025

  Dong, Sheng Jing ^a   de las Fuentes, Lisa ^a   Brown, Angela L ^a   Waggoner, Alan D ^a   Ewald, Gregory A ^a   Dávila Román, Víctor G ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PROTEIN BLOOD LEVEL; VELOCITY;

AMBULATORY CARE; BIOLOGICAL MARKERS; COHORT STUDIES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; STATISTICS; VENTRICULAR DYSFUNCTION, LEFT; WASHINGTON;

EID: 33746325156     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.echo.2006.03.012     Document Type: Article

References (48)

1. Yasue H., Yoshimura M., Sumida H., Kikuta K., Kugiyama K., Jougasaki M., et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90 (1994) 195-203
2. Holmes S.J., Espiner B.A., Richards A.M., Yandle T.G., and Frampton C. Renal, endocrine and hemodynamic effects of human brain natriuretic peptide in normal man. J Clin Endocrinol Metab 76 (1993) 91-96
3. Mair J., Friedl W., Thomas S., and Puschendorf B. Natriuretic peptides in assessment of left-ventricular dysfunction. Scand J Clin Lab Invest 59 (1999) 132-142
4. Lang C.C., Coutie W.J., Khong T.K., Choy A.M.J., and Struthers A.D. Dietary sodium loading increases plasma brain natriuretic peptide levels in man. J Hypertens 9 (1991) 779-882
5. Lang C.C., Choy A.M.J., Henderson I.S., Coutie W.J., and Struthers A.D. Effect of hemodialysis on plasma levels of brain natriuretic peptide in patients with chronic renal failure. Clin Sci (Colch) 82 (1992) 127-131
6. Hama N., Itoh H., Shirakami G., Nakagawa O., Suga S., Ogawa Y., et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 92 (1995) 1558-1564
7. Luchner A., Stevens T.L., Borgeson D.D., Redfield M., Wei C.M., Porter J.G., et al. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. Am J Physiol 274 (1998) H1684-H1689
8. Maeda K., Tsutamoto T., Wada A., Hisanaga T., and Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 135 (1998) 825-832
9. Kazanegra R., Cheng V., Garcia A., Krishnaswamy P., Gardetto N., Clopton P., et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure. a pilot study. J Card Fail 7 (2001) 21-29
10. Maisel A.S., Krishnaswamy P., Nowak R.M., McCord J., Hoolander J.E., Duc P., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
11. McCullough P.A., Nowak R.M., McCord J., Hollander J.E., Herrmann H.C., Steg P.G., et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure. analysis from breathing not properly (BNP) multinational study. Circulation 106 (2002) 416-422
12. Logeart D., Saudubary C., Beyne P., Thabut G., Ennezat P.V., Chavelas C., et al. Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea. J Am Coll Cardiol 40 (2002) 1794-1800
13. Maisel A.S., McCord J., Nowak R.M., Hollander J.E., Wu A.H.B., Duc P., et al. Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. J Am Coll Cardiol 41 (2003) 2010-2017
14. Yamamoto K., Burnett Jr. J.C., Bermudez E.A., Jougasaki M., Bailey K.R., and Redfield M.M. Clinical criteria and biochemical markers for the detection of systolic dysfunction. J Card Fail 6 (2000) 194-200
15. Hammerer-Lercher A., Neubauer E., Muller S., Pachinger O., Puschendorf B., and Mair J. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. Clin Chim Acta 310 (2001) 193-197
16. Yamamota K., Burnett J.C., Jougasaki M., Nishimura R.A., Bailey K.R., Saito Y., et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 28 (1996) 988-994
17. Lubien E., DeMaria A., Krishnaswamy P., Clopton P., Koon J., Kazanegra R., et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction. comparison with Doppler velocity recording. Circulation 105 (2002) 595-601
18. Richards A.M., Crozier I.G., Yandle T.G., Espiner E.A., Ikram H., and Nicholls M.G. Brain natriuretic factor. regional plasma concentrations and correlations with hemodynamic state in cardiac disease. Br Heart J 69 (1993) 414-417
19. Hunt P.J., Richards A.M., Nicholis M.G., Yandle T.G., Doughty R.N., and Espiner E.A. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-proBNP). a new marker of cardiac impairment. Clin Endocrinol 47 (1997) 287-296
20. Hobbs F.D.R., Davis R.C., Roalfe A.K., Hare R., Davies M.K., and Kenkre J.E. Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure. cohort study in representative and high risk community population. BMJ 324 (2002) 1498-1502
21. Luchner A., Hengstenberg C., Lowel H., Trawinski J., Baumann M., Riegger A.J., et al. N-terminal pro-brain natriuretic peptide after myocardial infarction. a marker of cardio-renal function. Hypertension 39 (2002) 99-104
22. Bay M., Kirk V., Parner J., Hassager C., Nielsen H., Krogsgaard K., et al. NT-proBNP. a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function. Heart 89 (2003) 150-154
23. Richards A.M., Nicholls M.G., Yandle T.G., Frampton C., Espiner E.A., Turner J.G., et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin. new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 97 (1998) 1921-1929
24. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease. evaluation, classification, and stratification. Am J Kidney Dis 39 (2002) S1-S244
25. Sahn D.J., DeMaria A., Kisslo J., Weyman A., and Committee on M-Mode Standardization of the American Society of Echocardiography. Recommendation regarding quantitation in M-mode echocardiography. results of a survey of echocardiographic measurements. Circulation 58 (1978) 1072-1083
26. Reichek N., Wilson J., St John Sutton M., Plappert T.A., Goldberg S., and Hirshfeld J.W. Noninvasive determination end-systolic stress. validation of the method and initial application. Circulation 65 (1982) 99-109
27. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., et al. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 2 (1989) 358-367
28. Quiñones M.A., Otto C.M., Stoddard M., Waggoner A., and Zoghbi W.A. Recommendations for quantification of Doppler echocardiography. a report from the Doppler quantification task force of the nomenclature and standards committee of the American Society of Echocardiography. J Am Soc Echocardiogr 15 (2002) 167-184
29. Nagueh S.F., Middleton K.J., Kopelen H.A., Zoghbi W.A., and Quiñones M.A. Doppler tissue imaging. a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 30 (1997) 1527-1533
30. Ommen S.R., Nishimura R.A., Appleton C.P., Miller F.A., Oh J.K., Redfield M.M., et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures. a simultaneous Doppler-catheterization study. Circulation 102 (2000) 1788-1794
31. Yu C.M., Sanderson J.E., Shum I.O.L., Chan S., Yeung L.Y.C., Hung Y.T., et al. Diastolic dysfunction and natriuretic peptides in systolic heart failure. higher ANP and BNP levels are associated with restrictive filling pattern. Eur Heart J 17 (1996) 1694-1702
32. Masson S., Vago T., Baldi G., Salio M., De Angelis N., Nicolis E., et al. Comparative measurement of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in ambulatory patients with heart failure. Clin Chem Lab Med 40 (2002) 761-763
33. Lainchbury J.G., Campbell E., Frampton C.M., Yandle T.G., Nicholls M.G., and Richards A.M. Brain natriuretic peptide and N-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol 42 (2003) 728-735
34. Kitzman D.W., Little W.C., Brubaker P.H., Anderson R.T., Hundley W.G., Marburger C.T., et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 288 (2002) 2144-2150
35. Krishnaswamy P., Lubien E., Clopton P., Koon J., Kazanegra R., Wanner E., et al. Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction. Am J Med 111 (2001) 274-279
36. Cheung B.M. Plasma concentration of brain natriuretic peptide is related to diastolic function in hypertension. Clin Exp Pharmacol Physiol 24 (1997) 966-968
37. Fruhwald F.M., Fahrleitner A., Watzinger N., Fruhwald S., Dobnig H., Schumacher M., et al. Natriuretic peptides in patients with diastolic dysfunction due to idiopathic dilated cardiomyopathy. Eur Heart J 20 (1999) 1415-1423
38. Farias C.A., Rodriguez L., Garcia M.J., Sun J.P., Klein A.L., and Thomas J.D. Assessment of diastolic function by tissue Doppler echocardiography. comparison with standard transmitral and pulmonary venous flow. J Am Soc Echocardiogr 12 (1999) 609-617
39. Nagueh S.F., Sun H., Kopelen H.A., Middleton K.J., and Khoury D.S. Hemodynamic determinants of mitral annulus diastolic velocities by tissue Doppler. J Am Coll Cardiol 37 (2001) 278-285
40. Redfield M.M., Rodeheffer R.J., Jacobsen S.J., Mahoney D.W., Bailey K.R., and Burnett Jr. J.C. Plasma brain natriuretic peptide concentration. impact of age and gender. J Am Coll Cardiol 40 (2002) 976-982
41. Wang T.J., Larson M.G., Levy D., Leip E.P., Benjamin E.J., Wilson P.W.F., et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol 90 (2002) 254-258
42. Clerico A., Caprioli R., Del Ry S., and Gianness D. Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competetive immunoassay methods in patients with renal failure on chronic hemodialysis. J Endocrinol Invest 24 (2001) 30
43. Luchner A., Burnett J.C., Jougasaki M., Hense H.W., Heid I.M., Muders F., et al. Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population. J Hypertens 18 (2000) 1121-1128
44. Yasumoto K., Takata M., Ueno H., Tomita S., Tomoda F., and Inoue H. Relation of plasma brain and atrial natriuretic peptides to left ventricular geometric patterns in essential hypertension. Am J Hypertens 12 (1999) 921-924
45. Talwar S., Siebenhofer A., Williams B., and Ng L. Influence of hypertension, left ventricular hypertrophy, and left ventricular systolic dysfunction on plasma N terminal proBNP. Heart 83 (2000) 278-282
46. Rivas-Gotz C., Manolios M., Thohan V., and Nagueh S.F. Impact of left ventricular ejection fraction on estimation of left ventricular filling pressures using tissue Doppler and flow propagation velocity. Am J Cardiol 91 (2003) 780-784
47. Rihal CS, Nishimura RA, Hatle LK, Bailey KR, Tajik AJ. Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy: relation to symptoms and prognosis. Circulation 199;90:2772-9.
48. Vanoverschelde J.L.J., Raphael D.A., Robert A.R., and Cosyns J.R. Left ventricular filling in dilated cardiomyopathy. relation to functional class and hemodynamics. J Am Coll Cardiol 15 (1990) 1288-1295